Management of the Most Common Functional Gastrointestinal Disorders in Infancy: The Middle East Expert Consensus

Flavia Indrio1, Axel Enninger2, Wajeeh Aldekhail3

  • 1Department of Medical and Surgical Science, University of Foggia, Foggia, Italy.

Insights

Functional gastrointestinal disorders (FGIDs) are common in infants. A new consensus offers a simplified, standardized treatment protocol for FGIDs in the Middle East, improving infant care.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Microbiome

Background:

  • Functional gastrointestinal disorders (FGIDs) present significant challenges for infants, parents, and healthcare providers.
  • Data on FGIDs in the Middle East are limited, yet the conditions are considered prevalent in clinical practice.
  • The Rome IV criteria offer updated definitions for FGIDs, aiming for consistent diagnosis.

Purpose of the Study:

  • To address the variability in FGID treatment practices across Middle Eastern countries.
  • To develop a locally relevant, simplified treatment plan for common infant FGIDs.
  • To provide a standardized protocol for primary care physicians managing FGIDs.

Main Methods:

  • A consensus meeting involving regional experts was convened.
  • Discussion and approval of a locally relevant approach for treating infant regurgitation, colic, and functional constipation.
  • Development of a simplified, easy-to-follow treatment protocol.

Main Results:

  • A consensus was reached on a standardized treatment protocol for common infant FGIDs.
  • The protocol aims to streamline initial management by general pediatricians and primary care physicians.
  • The approach considers various treatment modalities, including probiotics like *Lactobacillus reuteri* DSM 17938.

Conclusions:

  • The developed protocol offers a standardized approach to managing FGIDs in the Middle East.
  • This initiative seeks to reduce mismanagement and improve patient outcomes.
  • The protocol has potential for global application in managing infant FGIDs.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
465
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
277
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
692
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
465
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
41
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
398